{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:42:37Z","timestamp":1788306157029,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clinthera.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T23:39:31Z","timestamp":1613432371000},"page":"438-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Advances in the Epidemiology, Diagnosis, and Management of Pediatric Fatty Liver Disease"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-2909","authenticated-orcid":false,"given":"Anandini","family":"Suri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-8108","authenticated-orcid":false,"given":"Eric","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4157-118X","authenticated-orcid":false,"given":"Johan","family":"van Nispen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8994-5243","authenticated-orcid":false,"given":"Austin","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidul","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.01.006_bib1","doi-asserted-by":"crossref","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2021.01.006_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2021.01.006_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jpeds.2012.08.043","article-title":"Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010","volume":"162","author":"Welsh","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib4","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/j.2047-6310.2012.00089.x","article-title":"The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk?","volume":"7","author":"Nobili","year":"2012","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.clinthera.2021.01.006_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/ajg.2010.152","article-title":"Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease","volume":"105","author":"Patton","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCG.0000000000000925","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in young adults in the United States","volume":"52","author":"Doycheva","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib8","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes","volume":"62","author":"Cholankeril","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2021.01.006_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hep.29473","article-title":"Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States","volume":"70","author":"Parikh","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2021.01.006_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of nonalcoholic fatty liver disease in children with obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/apt.14900","article-title":"Hepatic steatosis is highly prevalent across the paediatric age spectrum, including in pre-school age children","volume":"48","author":"Dhaliwal","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.01.006_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2018.04.047","article-title":"Pediatric nonalcoholic fatty liver disease in New York City: an autopsy study","volume":"200","author":"Fernandes","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/ijmr.IJMR_1966_16","article-title":"Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents","volume":"148","author":"Jain","year":"2018","journal-title":"Ind J Med Res"},{"key":"10.1016\/j.clinthera.2021.01.006_bib16","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.3346\/jkms.2018.33.e109","article-title":"Estimated prevalence of adolescents with nonalcoholic fatty liver disease in Korea","volume":"33","author":"Kang","year":"2018","journal-title":"J\u00a0Kor Med Sci"},{"key":"10.1016\/j.clinthera.2021.01.006_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s13312-017-1202-3","article-title":"Prevalence of nonalcoholic fatty liver disease in normal-weight and overweight preadolescent children in Haryana, India","volume":"54","author":"Das","year":"2017","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12887-017-0867-z","article-title":"Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity","volume":"17","author":"Jimenez-Rivera","year":"2017","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph14050465","article-title":"Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese children","volume":"14","author":"Song","year":"2017","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.clinthera.2021.01.006_bib20","first-page":"853","article-title":"Most overweight and obese Indian children have nonalcoholic fatty liver disease","volume":"15","author":"Pawar","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MCG.0000000000000121","article-title":"Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children","volume":"49","author":"Malespin","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib22","first-page":"281","article-title":"Nonalcoholic fatty liver disease prevalence in urban school-aged children and adolescents from the Yangtze River delta region: a cross-sectional study","volume":"24","author":"Zhang","year":"2015","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib23","first-page":"76","article-title":"Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt","volume":"15","author":"Alkassabany","year":"2014","journal-title":"Arab J Gastroenterol Off Publ Pan-arab Assoc Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib24","first-page":"23","article-title":"Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children","volume":"66","author":"Kodhelaj","year":"2014","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1515\/JPEM.2011.282","article-title":"The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children","volume":"24","author":"Gupta","year":"2011","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2021.01.006_bib26","first-page":"159","article-title":"Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures","volume":"29","author":"Alavian","year":"2009","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.clinthera.2021.01.006_bib27","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1053\/j.gastro.2007.08.077","article-title":"Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004","volume":"133","author":"Fraser","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib28","doi-asserted-by":"crossref","first-page":"31384","DOI":"10.1007\/s11356-019-06224-5","article-title":"Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents","volume":"26","author":"Chen","year":"2019","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.clinthera.2021.01.006_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1573396314666180124101521","article-title":"Predictors of non-alcoholic liver disease in ethnically diverse overweight children and adolescents","volume":"14","author":"Botero","year":"2018","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.clinthera.2021.01.006_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.pcl.2017.01.008","article-title":"Nonalcoholic fatty liver disease in children: hepatic and extrahepatic complications","volume":"64","author":"Selvakumar","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clinthera.2021.01.006_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.aohep.2019.04.012","article-title":"Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population","volume":"18","author":"Villanueva-Ortega","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12199-008-0074-5","article-title":"Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference","volume":"14","author":"Tominaga","year":"2009","journal-title":"Environ Health Prev Med"},{"key":"10.1016\/j.clinthera.2021.01.006_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.107.739920","article-title":"Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease","volume":"118","author":"Schwimmer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2021.01.006_bib34","doi-asserted-by":"crossref","first-page":"e112569","DOI":"10.1371\/journal.pone.0112569","article-title":"Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease","volume":"9","author":"Schwimmer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2021.01.006_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1203\/PDR.0b013e3181da4798","article-title":"Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease","volume":"67","author":"Nobili","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clinthera.2021.01.006_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1164\/rccm.201307-1339OC","article-title":"Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity\/insulin resistance","volume":"189","author":"Nobili","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2021.01.006_bib37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/hep.20140","article-title":"Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction","volume":"39","author":"Adams","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00535-004-1541-4","article-title":"Pediatric nonalcoholic steatohepatitis associated with hypopituitarism","volume":"40","author":"Nakajima","year":"2005","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian national association for the study of the liver, endocrine society of India, Indian college of cardiology and Indian society of gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fendo.2019.00514","article-title":"The liver in children with metabolic syndrome","volume":"10","author":"D'Adamo","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clinthera.2021.01.006_bib41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/apt.12518","article-title":"Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease","volume":"38","author":"Schwimmer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.01.006_bib42","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","article-title":"Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children","volume":"58","author":"Colantonio","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2021.01.006_bib43","first-page":"64","article-title":"Alanine aminotransferase as a monitoring biomarker in children with nonalcoholic fatty liver disease: a secondary analysis using TONIC trial data","volume":"5","author":"Arsik","year":"2018","journal-title":"Child (Basel, Switzerland)"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2021.01.006_bib44","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2021.01.006_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee","volume":"54","author":"Vajro","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cgh.2013.09.050","article-title":"Evidence and recommendations for imaging liver fat in children, based on systematic review","volume":"12","author":"Awai","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib47","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2021.01.006_bib48","first-page":"799","article-title":"Nonalcoholic fatty liver disease in children: a single center experience","volume":"6","author":"A-Kader","year":"2008","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.clinthera.2021.01.006_bib49","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.3748\/wjg.v22.i36.8078","article-title":"Pediatric non-alcoholic fatty liver disease: recent solutions, unresolved issues, and future research directions","volume":"22","author":"Clemente","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib50","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.30842","article-title":"Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials","volume":"70","author":"Anstee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib51","doi-asserted-by":"crossref","first-page":"16820","DOI":"10.3748\/wjg.v20.i45.16820","article-title":"Non-invasive diagnosis of advanced fibrosis and cirrhosis","volume":"20","author":"Sharma","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib52","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3748\/wjg.v18.i13.1525","article-title":"Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease","volume":"18","author":"Yang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib53","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s10620-014-3494-7","article-title":"The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease","volume":"60","author":"Mansoor","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2021.01.006_bib54","doi-asserted-by":"crossref","first-page":"e104558","DOI":"10.1371\/journal.pone.0104558","article-title":"The development of the pediatric NAFLD Fibrosis Score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease","volume":"9","author":"Alkhouri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2021.01.006_bib55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/hep.22376","article-title":"Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib56","article-title":"Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity","author":"Runge","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpeds.2013.07.050","article-title":"Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease","volume":"164","author":"Xanthakos","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/oby.20173","article-title":"Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children","volume":"21","author":"Koot","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.clinthera.2021.01.006_bib59","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MPG.0b013e3181e376be","article-title":"Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD","volume":"51","author":"Fitzpatrick","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib60","first-page":"2121","article-title":"Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease","volume":"12","author":"Vuppalanchi","year":"2014","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.clinthera.2021.01.006_bib61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2217\/bmm.13.13","article-title":"Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease","volume":"7","author":"Boyraz","year":"2013","journal-title":"Biomark Med"},{"key":"10.1016\/j.clinthera.2021.01.006_bib62","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fped.2019.00420","article-title":"Including fibroblast growth factor-21 in combined biomarker panels improves predictions of liver steatosis severity in children","volume":"7","author":"Hua","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib63","doi-asserted-by":"crossref","first-page":"2102401","DOI":"10.1155\/2020\/2102401","article-title":"Endocan and lumican in relation to cardiometabolic risk in a pediatric overweight and obese cohort: a cross-sectional study","volume":"2020","author":"B\u0103l\u0103nescu","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clinthera.2021.01.006_bib64","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/MEG.0000000000001608","article-title":"Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter","volume":"32","author":"Elkabany","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib65","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jama.2018.20579","article-title":"Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial","volume":"321","author":"Schwimmer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2021.01.006_bib66","doi-asserted-by":"crossref","first-page":"e12630","DOI":"10.1111\/ijpo.12630","article-title":"Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: a pilot, randomized trial","volume":"15","author":"Goss","year":"2020","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.clinthera.2021.01.006_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5604\/01.3001.0011.7380","article-title":"Non-alcoholic fatty liver disease in children and adolescents: lifestyle change\u2014a systematic review and meta-analysis","volume":"17","author":"Utz-Melere","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib68","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2020.07.034","article-title":"Progression of fatty liver disease in children receiving standard of care lifestyle advice","volume":"159","author":"Xanthakos","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib69","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.clinthera.2008.06.012","article-title":"Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study","volume":"30","author":"Nobili","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2021.01.006_bib70","first-page":"1417","article-title":"Effect of vitamin E and metformin on fatty liver disease in obese children\u2014randomized clinical trial","volume":"43","author":"Shiasi Arani","year":"2014","journal-title":"Iran J Publ Health"},{"key":"10.1016\/j.clinthera.2021.01.006_bib71","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1024\/0300-9831\/a000086","article-title":"Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver","volume":"81","author":"Akcam","year":"2011","journal-title":"Int J Vitam Nutr Res Int Z Vitamin- Ernahrungsforschung J Int Vitaminol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib72","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.039206","article-title":"Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in\u00a0vivo model of early obesity and non-alcoholic fatty liver disease","volume":"12","author":"Carbajo-Pescador","year":"2019","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.clinthera.2021.01.006_bib73","doi-asserted-by":"crossref","first-page":"e2019226","DOI":"10.1590\/1984-0462\/2021\/39\/2019226","article-title":"The therapeutic impact of probiotics on nonalcoholic fatty liver disease in pediatrics: a systematic review","volume":"39","author":"Chaves","year":"2021","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib74","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1053\/j.gastro.2016.08.027","article-title":"In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores","volume":"151","author":"Schwimmer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpeds.2018.02.038","article-title":"Clinically actionable hypercholesterolemia and hypertriglyceridemia in children with nonalcoholic fatty liver disease","volume":"198","author":"Harlow","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib76","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib77","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.3748\/wjg.v20.i23.7347","article-title":"Pediatric fatty liver disease: role of ethnicity and genetics","volume":"20","author":"Marzuillo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib78","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinthera.2021.01.006_bib79","first-page":"569","article-title":"Prevalence of suspected nonalcoholic fatty liver disease in Hispanic\/Latino individuals differs by heritage","volume":"13","author":"Kallwitz","year":"2015","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.clinthera.2021.01.006_bib80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.numecd.2010.05.006","article-title":"Racial\/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors","volume":"22","author":"Walker","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.clinthera.2021.01.006_bib81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pcad.2014.08.004","article-title":"Challenges in preventing heart disease in Hispanics: early lessons learned from the hispanic community health study\/study of latinos (HCHS\/SOL)","volume":"57","author":"Schneiderman","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.clinthera.2021.01.006_bib82","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2012.14517","article-title":"Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic\/Latino individuals of diverse backgrounds in the United States","volume":"308","author":"Daviglus","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2021.01.006_bib83","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.amjmed.2014.07.026","article-title":"Dyslipidemia patterns among Hispanics\/Latinos of diverse background in the United States","volume":"127","author":"Rodriguez","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2021.01.006_bib84","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1210\/jc.2009-1125","article-title":"Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance","volume":"94","author":"Denzer","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2021.01.006_bib85","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jpeds.2013.10.072","article-title":"Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease","volume":"164","author":"Sundaram","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib86","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00431-019-03362-3","article-title":"Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease","volume":"178","author":"Draijer","year":"2019","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib87","article-title":"Alanine aminotransferase and gamma-glutamyl transpeptidase predict histologic improvement in pediatric nonalcoholic steatohepatitis","author":"Newton","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib88","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5223\/pghn.2020.23.3.276","article-title":"A\u00a0nomogram for predicting non-alcoholic fatty liver disease in obese children","volume":"23","author":"Kim","year":"2020","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib89","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0009922817733300","article-title":"Challenges in screening for pediatric nonalcoholic fatty liver disease","volume":"57","author":"Ferguson","year":"2017","journal-title":"Clin Pediatr (Phila)."},{"key":"10.1016\/j.clinthera.2021.01.006_bib90","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1111\/apa.15294","article-title":"Survey on screening for paediatric non-alcoholic fatty liver disease in clinical practice in Dutch hospitals","volume":"109","author":"Draijer","year":"2020","journal-title":"Acta Paediatr"},{"issue":"5","key":"10.1016\/j.clinthera.2021.01.006_bib107","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1665-2681(19)31317-1","article-title":"Primary care practitioners survey of non-alcoholic fatty liver disease","volume":"12","author":"Said","year":"2013","journal-title":"Ann Hepatol"},{"issue":"10","key":"10.1016\/j.clinthera.2021.01.006_bib108","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s10620-013-2740-8","article-title":"Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease","volume":"58","author":"Wieland","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2021.01.006_bib91","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.20842","article-title":"Histopathology of pediatric nonalcoholic fatty liver disease","volume":"42","author":"Schwimmer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib92","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1097\/MCG.0b013e3181cf8358","article-title":"Safety of blind percutaneous liver biopsy in obese children: a retrospective analysis","volume":"44","author":"Harwood","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib93","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s00247-012-2433-z","article-title":"Effectiveness and safety of ultrasound-guided percutaneous liver biopsy in children","volume":"42","author":"Matos","year":"2012","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib94","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.2010.214650","article-title":"Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?","volume":"59","author":"Castera","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2021.01.006_bib95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/17530059.2012.713343","article-title":"Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy","volume":"6","author":"Alisi","year":"2012","journal-title":"Expert Opin Med Diagn"},{"key":"10.1016\/j.clinthera.2021.01.006_bib96","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/00365521.2019.1583366","article-title":"Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)","volume":"54","author":"\u00d6nnerhag","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib97","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-015-0447-z","article-title":"A\u00a0comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease","volume":"17","author":"Mansoor","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.clinthera.2021.01.006_bib98","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.01.006_bib99","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPG.0b013e31826f2760","article-title":"Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease","volume":"56","author":"Fitzpatrick","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib100","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/hep.29241","article-title":"Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease","volume":"66","author":"Schwimmer","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2021.01.006_bib101","doi-asserted-by":"crossref","first-page":"e3437","DOI":"10.1210\/clinem\/dgaa467","article-title":"Sex-specific metabolite biomarkers of NAFLD in youth: a prospective study in the EPOCH cohort","volume":"105","author":"Perng","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2021.01.006_bib102","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MPG.0000000000002875","article-title":"Lipidomics in nonalcoholic fatty liver disease: exploring serum lipids as biomarkers for pediatric nonalcoholic fatty liver disease","volume":"71","author":"Draijer","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib103","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000001624","article-title":"Systematic review: nutrition and physical activity in the management of paediatric nonalcoholic fatty liver disease","volume":"65","author":"Gibson","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2021.01.006_bib104","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial","volume":"96","author":"Nobili","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clinthera.2021.01.006_bib105","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"issue":"10215","key":"10.1016\/j.clinthera.2021.01.006_bib106","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet (London, England)"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:53:49Z","timestamp":1758963229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0149291821000102"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.01.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Epidemiology, Diagnosis, and Management of Pediatric Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}